Top Categories
Products
Add Listing
GRN-300 | Greenfire Bio
Product description
GRN-300 is a first-in-class small molecule SIK2/3 inhibitor currently in a Phase 1 clinical trial for ovarian cancer and triple-negative breast cancer (TNBC).
Greenfire Bio
Frisco, United States (US)
Price:
N/A
Quote request
Message
